Breaking News

You are here » Indian-Commodity  :  Corporate  :  Alembic Pharma gets USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

14-Sep2018

Alembic Pharma gets USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), KAZANO Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg of Takeda Pharma USA. Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg are indicated as an adjunct to diet and exercise to improve giycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and metformin is appropriate.

Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg has an estimated market size of $22.5 million for twelve months ending December 2017 according to IQVIA. Alembic now has a total of 77 ANDA approvals (64 final approvals and 13 tentative approvals) from USFDA. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Related News

View all news

Sun Pharma reports consolidated net loss of Rs 219 crore in Q2

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2018.The company has reported net loss of Rs 906.42 crore for the quarter under review, as against net profit of......

Allahabad Bank planning to raise additional Rs 1,800-1,900 crore

Allahabad Bank is planning to raise additional Rs 1,800-1,900 crore to shore up capital adequacy. The Bank is exploring all options - government help, QIP, and hiving off non-core assets and stake in JVs.Allahabad......

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Top News

View all news

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Govt in favour of alignment of capital adequacy norms with Basel III norms

Instead of present stricter guidelines which restrict the lending capacity of lenders, the government is of the view that the Reserve Bank of India (RBI) should resort to Basel III norms for capital adequacy......

Infosys, Ashok Leyland and Reliance Infrastructure to see some action today

Infosys will open its next Technology and Innovation Hub in the State of Texas and hire 500 American workers in the state by 2020. The Hub will be located in Richardson, Texas and have a special focus......